Steven Stone
About
Steven Stone is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology.
According to data from OpenAlex, Steven Stone has authored 71 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 32 papers in Cancer Research and 18 papers in Oncology. Recurrent topics in Steven Stone's work include Prostate Cancer Treatment and Research (39 papers), Cancer, Lipids, and Metabolism (26 papers) and Prostate Cancer Diagnosis and Treatment (24 papers). Steven Stone is often cited by papers focused on Prostate Cancer Treatment and Research (39 papers), Cancer, Lipids, and Metabolism (26 papers) and Prostate Cancer Diagnosis and Treatment (24 papers). Steven Stone collaborates with scholars based in United States, United Kingdom and Germany. Steven Stone's co-authors include David Parry, Jerry S. Lanchbury, Julia Reid, Alexander Gutin, Rosalind Smith, Eiji Hara, Hidetoshi Tahara, Gordon Peters, Adib Younus and Alexander Kamb and has published in prestigious journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and Brain Research.
In The Last Decade
Steven Stone
69 papers receiving 4.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Steven Stone United States | 27 | 2.1k | 1.7k | 1.6k | 1.3k | 470 | 71 | 4.7k | ||
| Peter C. Phillips∥ United States | 49 | 1.2k 0.6× | 3.0k 1.8× | 860 0.5× | 661 0.5× | 509 1.1× | 136 | 7.5k | ||
| Maryam Fouladi United States | 45 | 1.2k 0.6× | 2.5k 1.4× | 932 0.6× | 579 0.5× | 356 0.8× | 205 | 6.0k | ||
| Stephen T. Keir United States | 46 | 1.2k 0.6× | 3.2k 1.8× | 2.1k 1.3× | 972 0.8× | 211 0.4× | 168 | 5.8k | ||
| Jane Beith Australia | 35 | 718 0.3× | 691 0.4× | 2.6k 1.6× | 917 0.7× | 605 1.3× | 124 | 3.9k | ||
| Jan Cools Belgium | 55 | 1.4k 0.7× | 3.0k 1.7× | 1.8k 1.1× | 693 0.5× | 791 1.7× | 185 | 8.5k | ||
| Virginia F. Borges United States | 48 | 1.4k 0.7× | 1.4k 0.8× | 4.8k 3.0× | 1.8k 1.4× | 400 0.9× | 227 | 7.2k | ||
| Sridharan Gururangan United States | 42 | 1.8k 0.9× | 2.4k 1.4× | 1.3k 0.8× | 1.5k 1.1× | 271 0.6× | 118 | 6.8k | ||
| Catherine Ellis United States | 28 | 742 0.4× | 1.2k 0.7× | 2.1k 1.3× | 518 0.4× | 460 1.0× | 99 | 5.1k | ||
| Darren Hargrave United Kingdom | 38 | 769 0.4× | 1.8k 1.0× | 779 0.5× | 687 0.5× | 199 0.4× | 187 | 5.5k | ||
| Jonathan S. T. Sham Hong Kong | 38 | 849 0.4× | 1.6k 0.9× | 1.4k 0.9× | 634 0.5× | 1.1k 2.3× | 80 | 4.1k |
Countries citing papers authored by Steven Stone
Since
Specialization
Citations
This map shows the geographic impact of Steven Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Stone more than expected).
Fields of papers citing papers by Steven Stone
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Steven Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Stone. The network helps show where Steven Stone may publish in the future.
Co-authorship network of co-authors of Steven Stone
This figure shows the co-authorship network connecting the top 25 collaborators of Steven Stone. A scholar is included among the top collaborators of Steven Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Stone. Steven Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ai, Rizi, Emma Roberts, Erica N. Montano, et al.. (2024). Skin Cancer Risk Is Increased by Somatic Mutations Detected Noninvasively in Healthy-Appearing Sun-Exposed Skin. Journal of Investigative Dermatology. 144(10). 2187–2196.e13.
2.
Kaufmann, Mark, Daniel M. Siegel, Michael Walker, et al.. (2024). Non-invasive Gene Expression Analysis Rules Out Melanoma with High Negative Predictive Value Regardless of Skin Phototype. SKIN The Journal of Cutaneous Medicine. 8(2). s384–s384.
3.
Tward, Jonathan D., Thorsten Schlomm, Daniel Canter, et al.. (2021). Personalizing Localized Prostate Cancer: Validation of a Combined Clinical Cell-cycle Risk (CCR) Score Threshold for Prognosticating Benefit From Multimodality Therapy. Clinical Genitourinary Cancer. 19(4). 296–304.e3.
4.
Tosoian, Jeffrey J., Adam S. Feldman, Rohit Mehra, et al.. (2020). Biopsy Cell Cycle Proliferation Score Predicts Adverse Surgical Pathology in Localized Renal Cell Carcinoma. European Urology. 78(5). 657–660.
5.
Morris, David, James S. Woods, Jennifer Logan, et al.. (2020). Prognostic capabilities and clinical utility of cell cycle progression testing, prostate imaging reporting and data system, version 2, and clinicopathologic data in management of localized prostate cancer. Urologic Oncology Seminars and Original Investigations. 39(6). 366.e19–366.e28.
6.
Canter, Daniel, Julia Reid, Shams Halat, et al.. (2018). Comparison of the Prognostic Utility of the Cell Cycle Progression Score for Predicting Clinical Outcomes in African American and Non-African American Men with Localized Prostate Cancer. European Urology. 75(3). 515–522.
7.
Léon, Priscilla, Géraldine Cancel‐Tassin, Marie Audouin, et al.. (2018). Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy. World Journal of Urology. 36(9). 1495–1500.
8.
Morgan, Todd M., Rohit Mehra, J. Stuart Wolf, et al.. (2017). A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma. European Urology. 73(5). 763–769.
9.
Cokley, Kevin, Leann V. Smith, Donte L. Bernard, et al.. (2017). Impostor feelings as a moderator and mediator of the relationship between perceived discrimination and mental health among racial/ethnic minority college students.. Journal of Counseling Psychology. 64(2). 141–154.
10.
Timms, Kirsten M., Jack Cuzick, Chris Neff, et al.. (2016). The molecular landscape of genome instability in prostate cancer (PC). Annals of Oncology. 27. vi35–vi35.
11.
Cuzick, Jack, Steven Stone, Gabrielle Fisher, et al.. (2015). Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort. British Journal of Cancer. 113(3). 382–389.
12.
Askeland, Eric J., et al.. (2015). Cell cycle progression score predicts metastatic progression of clear cell renal cell carcinoma after resection. Cancer Biomarkers. 15(6). 861–867.
13.
Cooperberg, Matthew R., Jeffry Simko, Janet E. Cowan, et al.. (2013). Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort. Journal of Clinical Oncology. 31(11). 1428–1434.
14.
Cuzick, Jack, Zi Yang, Gabrielle Fisher, et al.. (2013). Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer. British Journal of Cancer. 108(12). 2582–2589.
15.
Cuzick, Jack, Gregory P. Swanson, Gabrielle Fisher, et al.. (2011). Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. The Lancet Oncology. 12(3). 245–255.
16.
Esteva, Francisco J., Hua Guo, Siyuan Zhang, et al.. (2010). PTEN, PIK3CA, p-AKT, and p-p70S6K Status. American Journal Of Pathology. 177(4). 1647–1656.
17.
Laurent‐Puig, Pierre, Anne Cayre, Gilles Manceau, et al.. (2009). Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer. Journal of Clinical Oncology. 27(35). 5924–5930.
18.
Hunt, Steven C., Steven Stone, Yuanpei Xin, et al.. (2008). Association of the FTO Gene With BMI. Obesity. 16(4). 902–904.
19.
Stone, Steven, Victor Abkevich, Deanna L. Russell, et al.. (2006). TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predisposition. Human Molecular Genetics. 15(18). 2709–2720.
20.
Hattier, Thomas, Russell Bell, Daniel J. Shaffer, et al.. (1995). Monitoring the efficacy of hybrid selection during positional cloning: the search for BRCA1. Mammalian Genome. 6(12). 873–879.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Peter C. Phillips∥ Breakdown of academic impact, for papers by Maryam Fouladi Breakdown of academic impact, for papers by Stephen T. Keir Breakdown of academic impact, for papers by Jane Beith Breakdown of academic impact, for papers by Jan Cools Breakdown of academic impact, for papers by Virginia F. Borges Breakdown of academic impact, for papers by Sridharan Gururangan Breakdown of academic impact, for papers by Catherine Ellis Breakdown of academic impact, for papers by Darren Hargrave Breakdown of academic impact, for papers by Jonathan S. T. Sham